Resilience and recovery style: A retrospective study on associations among personal resources, symptoms, neurocognition, quality of life and psychosocial functioning in psychotic patients

Psychology Research and Behavior Management

Volumn 12, Issue , 2019, Pages 385-395

  Zizolfi, Daniele ^a   Poloni, Nicola ^a   Caselli, Ivano ^a   Ielmini, Marta ^a   Lucca, Giulia ^a   Diurni, Marcello ^a   Cavallini, Greta ^a   Callegari, Camilla ^a  

^a UNIVERSITY OF INSUBRIA   (Italy)

Author keywords

Cognition; Community functioning; Life quality; Mental health recovery; Psychological resilience; Schizophrenia

Indexed keywords

EID: 85067112263     PISSN: None     EISSN: 11791578     Source Type: Journal    
DOI: 10.2147/prbm.s205424     Document Type: Article

References (68)

1. Dean K, Murray RM. Environmental risk factors for psychosis. Dialogues Clin Neurosci. 2005;7(1):69–80.
2. Pruessner M, Cullen AE, Aas M, Walker EF. The neural diathesis-stress model of schizophrenia revisited: an update on recent findings considering illness stage and neurobiological and methodological complexities. Neurosci Biobehav Rev. 2017;73:191–218. doi:10.1016/j.neubiorev.2016.12.013
3. Caselli I, Poloni N, Ielmini M, Diurni M, Callegari C. Epidemiology and evolution of the diagnostic classification of factitious disorders in DSM-5. Psychol Res Behav Manag. 2017;10:387–394. doi:10.2147/PRBM.S153377
4. Callegari C, Berto E, Caselli I, Bressani R, Vender S. Multidisciplinary integrated approach to mental illness: semi-residen-tial setting and quality of life. Minerva Psichiatr. 2016;57(1):34–41.
5. Velthorst E, Reichenberg A, Ivanov I, et al. An integrative approach to test the relationship between social impairment and the development of psychosis. Schizophr Bull. 2017;43(1):S53. Epub 2017 March 20. doi:10.1093/schbul/sbx021.137
6. Wigman JT, de Vos S, Wichers M, van Os J, Bartels-Velthuis AA. A transdiagnostic network approach to psychosis. Schizophr Bull. 2017;43(1):122–132. doi:10.1093/schbul/sbw095 Epub 2016 Jul 6.
7. Diurni M, Baranzini F, Costantini C, Poloni N, Vender S, Callegari C. Metabolic side effects of second generation antipsychotics in drug-naive patients: a preliminary study. Riv Psichiatr. 2009;44(3):176– 178. Italian.
8. Bolla E, Bortolaso P, Ferrari M, et al. Are CYP1AA2*1F and *1C associated with clozapine tolerability? A preliminary investigation. Psychiatry Res. 2011;189(3):438. Epub 2011 Apr 8. doi:10.1016/j. psychres.2011.03.011
9. Albert U, Carmassi C, Cosci F, et al. Role and clinical implications of atypical antipsychotics in anxiety disorders, obsessive-compulsive disorder, trauma-related, and somatic symptom disorders: a systematized review. International Clin Psychopharmacol. 2016;31(5):249– 258. doi:10.1097/YIC.0000000000000127
10. Ostuzzi G, Mazzi MA, Terlizzi S, et al. Factors associated with first-versus second-generation long-acting antipsychotics prescribed under ordinary clinical practice in Italy. PLoS One. 2018;13(8):e0201371. doi10.1371/journal.pone.0201371 eCollection 2018.
11. Semisa D, Casacchia M, Di Munzio W, et al. Gruppo SIEP-DIRECT’S. Promoting recovery of schizophrenic patients: discrepancy between routine practice and evidence. The SIEP-DIRECT’S Project. Epidemiol Psichiatr Soc. 2008;17(4) Italian:331–349. doi:10.1017/S1121189X00000130
12. Oorschot M, Lataster T, Thewissen V, et al. Symptomatic remission in psychosis and real-life functioning. Br J Psychiatry. 2012;201 (3):215–220. Epub 2012 Jun 28. doi:10.1192/bjp.bp.111.104414
13. Kim KR, Song YY, Park JY, et al. The relationship between psychosocial functioning and resilience and negative symptoms in individuals at ultra-high risk for psychosis. Aust N Z J Psychiatry. 2013;47 (8):762–771. doi:10.1177/0004867413488218
14. Galderisi S, Rossi A, Rocca P, et al. Italian network for research on psychoses. The influence of illness-related variables, personal resources and context-related factors on real-life functioning of people with schizophrenia. World Psychiatry. 2014;13(3):275–287. doi:10.1002/wps.20167
15. Espinosa R, Valiente C, Rigabert A, Song H. Recovery style and stigma in psychosis: the healing power of integrating. Cogn Neuropsychiatry. 2016;21(2):146–155. doi:10.1080/13546805.2016.1147427 Epub 2016 Feb 29.
16. Rossi A, Galderisi S, Rocca P, et al. Italian network for research on psychoses. The relationships of personal resources with symptom severity and psychosocial functioning in persons with schizophrenia: results from the Italian network for research on psychoses study. Eur Arch Psychiatry Clin Neurosci. 2017;267(4):285–294. doi:10.1007/s00406-016-0710-9
17. Rossi A, Amore M, Galderisi S, et al. Italian network for research on psychoses. The complex relationship between self-reported ‘personal recovery’ and clinical recovery in schizophrenia. Schizophr Res. 2018;192:108–112.Epub 2017 May 9. doi10.1016/j.schres.2017.04.040
18. Luthar S. Resilience and Vulnerability: Adaptation in the Context of Childhood Adversities. New York: Cambridge University Press; 2003.
19. Rutter M. Implications of resilience concepts for scientific understanding. Ann N Y Acad Sci. 2006;1094:1–12. doi:10.1196/annals.1376.002
20. Callegari C, Bertù L, Caselli I, et al. Resilience in older adults: influence of the admission in nursing home and psychopatology. Neuropsychiatry. 2016a;6(4):117–123. doi:10.4172/Neuropsychiatry.1000129
21. Kim-Cohen J. Resilience and developmental psychopathology. Child Adolesc Psychiatr Clin N Am. 2007;16(2):271–283. doi:10.1016/j. chc.2006.11.003
22. Poloni N, Zizolfi D, Ielmini M, et al. A naturalistic study on the relationship among resilient factors, psychiatric symptoms, and psychosocial functioning in a sample of residential patients with psychosis. Psychol Res Behav Manag. 2018;11:123–131.eCollection 2018. doi10.2147/PRBM.S159571
23. Laudadio A, Fiz Perez F, Mazzocchetti L. Valutare La Resilienza. Teorie, Modelli E Strumenti. Roma: Carrocci; 2011. Italian.
24. Marulanda S, Addington J. Resilience in individuals at clinical high risk for psychosis. Early Interv Psychiatry. 2016;10(3):212–219. doi:10.1111/eip.12174
25. Morin L, Franck N. Rehabilitation interventions to promote recovery from schizophrenia: a systematic review. Front Psychiatry. 2017;12 (8):100. doi:10.3389/fpsyt.2017.00100
26. Jordan G, Malla A, Iyer SN. Posttraumatic growth following a first episode of psychosis: a mixed methods research protocol using a convergent design. BMC Psychiatry. 2016;25(16):262. doi:10.1186/s12888-016-0977-4
27. Mizuno Y, Wartelsteiner F, Frajo-Apor B. Resilience research in schizophrenia: a review of recent developments. Curr Opin Psychiatry. 2016;29(3):218–223. doi:10.1097/YCO.000000000000 0248
28. Christiani CJ, Jepsen JRM, Thorup A, et al. Social cognition, language, and social behavior in 7-year-old children at familial high-risk of developing schizophrenia or bipolar disorder: the danish high risk and resilience study via 7-a population-based cohort study. Schizophr Bull. 2019. doi:10.1093/schbul/sbz001
29. Henderson AR, Cock A. The responses of young people to their experiences of first-episode psychosis: harnessing resilience. Community Ment Health J. 2015;51(3):322–328. doi:10.1007/s10597-014-9769-9
30. Torgalsbøen AK, Fu S, Czajkowski N. Resilience trajectories to full recovery in first-episode schizophrenia. Eur Psychiatry. 2018;52:54– 60. doi:10.1016/j.eurpsy.2018.04.007
31. Salmon P, Dowrick C, Ring A, Humphris G. Voiced but unheard agendas: qualitative analysis of the psychosocial cues that patients with unexplained symptoms present to general practitioners. Br J Gen Pract. 2004;54(3):171–176.
32. Dowrick C, Kokanovic R, Hegarty K, Griffiths F, Gunn J. Resilience and depression: perspectives from primary care. Health (London). 2008;12(4):439–452. doi:10.1177/1363459308094419
33. O’Keeffe D, Hannigan A, Doyle R, et al. The iHOPE-20 study: relationships between and prospective predictors of remission, clinical recovery, personal recovery and resilience 20 years on from a first episode psychosis. Aust N Z J Psychiatry. 2019;6:486 7419827648.
34. Milioni M, Alessandri G, Eisenberg N, et al. Reciprocal relations between emotional self-efficacy beliefs and ego-resiliency across time. J Pers. 2015;83(5):552–563. doi:10.1111/jopy.12131
35. Gooding PA, Littlewood D, Owen R, Johnson J, Tarrier N. Psychological resilience in people experiencing schizophrenia and suicidal thoughts and behaviours. J Ment Health. 2017;28:1–7. doi:10.1080/09638237.2017.1294742
36. Rebagliati GA, Sciumè L, Iannello P, et al. Frailty and resilience in an older population. The role of resilience during rehabilitation after orthopedic surgery in geriatric patients with multiple comorbidities. Funct Neurol. 2016;31(3):171–177.
37. Bozikas VP, Parlapani E, Holeva V, et al. Resilience in patients with recent diagnosis of a schizophrenia spectrum disorder. J Nerv Ment Dis. 2016;204(8):578–584. doi:10.1097/NMD.0000000000000541
38. Poloni N, Diurni M, Buzzi A, et al. Recovery style, symptoms and psychosocial functioning in psychotic patients: a preliminary study. Riv Psichiatr. 2013;48(5) Italian:386–392. doi:10.1708/1356.15065
39. Callegari C, Caselli I, Bertù L, et al. Evaluation of the burden management in a psychiatric day center: distress and recovery style. Riv Psichiatr. 2016d;51(4):149–155. Italian.
40. Staring AB, van der Gaag M, Mulder CL. Recovery style predicts remission at one-year follow-up in outpatients with schizophrenia spectrum disorders. J Nerv Ment Dis. 2011;199(5):295–300. doi:10.1097/NMD.0b013e3182174e97
41. Cavelti M, Homan P, Vauth R. The impact of thought disorder on therapeutic alliance and personal recovery in schizophrenia and schi-zoaffective disorder: an exploratory study. Psychiatry Res. 2016;239:92–98. doi:10.1016/j.psychres.2016.02.070
42. Lemos-Giráldez S, García-Alvarez L, Paino M, et al. Measuring stages of recovery from psychosis. Compr Psychiatry. 2015;56:51– 58. doi:10.1016/j.comppsych.2014.09.021
43. Bell MD, Zito W. Integrated versus sealed-over recovery in Schizophrenia BORRTI and executive functions. J Nerv Ment Dis. 2005;193(1):3–8.
44. Rampling J, Furtado V, Winsper C, et al. Non-pharmacological interventions for reducing aggression and violence in serious mental illness: A systematic review and narrative synthesis. Eur Psychiatry. 2016;34:17–28. doi:10.1016/j.eurpsy.2016.01.2422
45. Pilling S, Bebbington P, Kuipers E, et al. Psychological treatments in schizophrenia: II. Meta-analyses of randomized controlled trials of social skills training and cognitive remediation. Psychol Med. 2002;32(5):783–791. doi:10.1017/S0033291702005640
46. Harrow M, Jobe TH. Factors involved in outcome and recovery in schizophrenia patients not on antipsychotic medication: a 15-year multifollow-up study. J Nerv Ment Dis. 2007;195(5):406–414.
47. Rudnick A, Martins J. Coping and schizophrenia: a re-analysis. Arch Psychiatr Nurs. 2009;23(1):11–15. doi:10.1016/j.apnu.2008.02.009
48. Poloni N, Armani S, Ielmini M, et al. Characteristics of the caregiver in mental health: stress and strain. Minerva Psichiatr. 2017;58 (3):118–124.
49. Girtler N, Casari EF, Brugnolo A, et al. Italian validation of the Wagnild and Young Resilience Scale: a perspective to rheumatic diseases. Clin Exp Rheumatol. 2010;28(5):669–678.
50. Wagnild GM, Young HM. Development and psychometric evaluation of the resilience scale. J Nurs Meas. 1993;1:165–178.
51. Callegari C, Bertù L, Lucano M, Ielmini M, Braggio E, Vender S. Reliability and validity of the Italian version of the 14-item resilience scale. Psychol Res Behav Manag. 2016c;3(9):277–284. doi:10.2147/PRBM.S115657
52. Wagnild GM, Collins JA. Assessing Resilience. J Psychosoc Nurs Ment Health Serv. 2009;47(12):28–33. doi:10.3928/02793695-20091103-01
53. Poloni N, Callegari C, Buzzi A, et al. The Italian version of ISOS and RSQ, two suitable scales for investigating recovery style from psychosis. Epidemiol Psichiatr Soc. 2010;19(4):352–359. Italian.
54. Nasreddine ZS, Phillips NA, Bédirian V, et al. The montreal cognitive assessment, MOCA: a brief screening tool for mild cognitive impairment. J Am Geriatr Soc. 2009;53(4):695–699. doi:10.1111/j.1532-5415.2005.53221.x
55. Conti S, Bonazzi S, Laiacona M, Masina M, Coralli MV. Montreal Cognitive Assessment (MoCA)-Italian version: regression based norms and equivalent scores. Neurol Sci. 2015;36(2):209–214. doi:10.1007/s10072-014-1921-3 Epub 2014 Aug 20.
56. Wilkinson G, Hesdon B, Wild D, et al. Self-report quality of life measure for people with schizophrenia: the SQLS. Br J Psychiatry. 2000;177:42–46.
57. Rosen A, Hadzi-Pavlov D, Parker G. The Life Skills Profile: a measure assessing function and disability in schizophrenia. Schizophr Bull. 1989;15(2):325–337. doi:10.1093/schbul/15.2.325
58. Zizolfi S. The Italian version of Life Skills Profile (LSP), an instrument for evaluating performance and disabilities of schizophrenic patients. Epidemiol Psichiatr Soc. 1997;6(3):196–204. Italian. doi:10.1017/S1121189X00005054
59. Kay SR, Fiszbein A, Opler LA. The Positive and Negative Syndrome Scale (PANSS) for Schizophrenia. Schizophr Bull. 1987;13(2):261– 276. doi:10.1093/schbul/13.2.261
60. Llorca PM, Blanc O, Samalin L, Bosia M, Cavallaro R. Factors involved in the level of functioning of patients with schizophrenia according to latent variable modeling. Eur Psychiatry. 2012;27 (6):396–400. doi:10.1016/j.eurpsy.2011.01.010
61. Hogarty GE. Personal Therapy for Schizophrenia and Related Disorders: A Guide to Individualized Treatment. New York: Guilford; 2002.
62. Tandon R, Nasrallah HA, Keshavan MS. Schizophrenia, “just the facts” 5: treatment and prevention. Past, present, and future. Schizophr Res. 2010;122(1–3): 1–23. doi:10.1016/j.schres.2010.05.025
63. Mc Gurk SR, Twamley EW, Sitzer DI, McHugo GJ, Mueser KT. A meta-analysis on cognitive remediation in schizophrenia. Am J Psychiatry. 2007;164(12):1791–1802. doi:10.1176/appi.ajp.2007. 07060906
64. Wykes T, Huddy V, Cellard C, McGurk SR, Czobor P. A meta-analysis of cognitive remediation for schizophrenia: methodology and effect sizes. Am J Psychiatry. 2011;168(5):472–485. doi:10.1176/appi.ajp.2010.10060855
65. Benaiges I, Serra-Grabulosa JM, Adan A. Neuropsychological functioning and age-related changes in schizophrenia and/or cocaine dependence. Prog Neuropsychopharmacol Biol Psychiatry. 2013;40:298–305. doi:10.1016/j.pnpbp.2012.10.016
66. Benaiges I, Prat G, Adan A. Health-related quality of life in patients with dual diagnosis: clinical correlates. Health Qual Life Outcomes. 2012;5(10):106. doi:10.1186/1477-7525-10-106
67. Adan A, Arredondo AY, Capella MD, Prat G, Forero DA, Navarro JF. Neurobiological underpinnings and modulating factors in schizophrenia spectrum disorders with a comorbid substance use disorder: A systematic review. Neurosci Biobehav Rev. 2017;75:361–377. doi:10.1016/j.neubiorev.2017.01.038
68. Benaiges I, Serra-Grabulosa JM, Prat G, Adan A. Executive functioning in individuals with schizophrenia and/or cocaine dependence. Hum Psychopharmacol. 2013;28(1):29–39. doi:10.1002/hup.2279